Frontlight ResearchEarly access
Active, not recruitingNo phase
Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion
Key facts
- Who runs it
- Milton S. Hershey Medical Center
- Where
- Boston, Cincinnati, Hershey, New York, and Syracuse, United StatesSee the 5 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 750 people, planned
- Started
- 18 Jan 2021
- Expected to end
- Dec 2027
- Type of study
- Observational
- Record updated
- 8 September 2026
Who can take part
- Age
- 5 years to 24 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Presence of mTBI: defined by criteria from the Berlin Consensus Statement and WHO. Assessment for mTBI status be performed by a licensed clinician per the 2018 CDC guidelines
- Age at enrollment: 5-24 years of age (inclusive)
Who cannot take part
- Previous moderate-to-severe TBI requiring overnight hospitalization
- Unresolved symptoms from previous concussion, or any concussion within the last 3 months
- Psychiatric illness requiring previous hospitalization
- Previous neurosurgery
- Previously enrolled in the same study
- Neurological condition (e.g. epilepsy, hydrocephalus) or abnormality on neuroimaging (if performed)
- Upper respiratory infection
- Periodontal infection
- >7d after initial mTBI
- Glasgow Coma Scale score of 13 or less
- Abbreviated Injury Scale (AIS) score > 3 (to reduce confounding from poly-trauma)
- Intellectual disability that prevents ability to provide informed assent
- Pregnancy
- Active substance use/dependence
- Non-fluency in English
- Injury to the oropharynx
- Inability to complete follow-up assessments
Where in United States
- Boston Children's HosptialBoston, United States
- Cincinnati Children's Hospital Medical CenterCincinnati, United States
- Penn State Milton S. Hershey Medical CenterHershey, United States
- Weill Cornell Medicine-New York Presbyterian HospitalNew York, United States
- SUNY Upstate Medical UniversitySyracuse, United States
About the trial
What the trial wants to find out
The purpose of this study is to identify changes in salivary micro ribonucleic acid (miRNA) levels that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 8 September 2026